1998
DOI: 10.1002/(sici)1098-1101(1998)13:3<103::aid-jca2>3.0.co;2-g
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial decontamination of blood stem cell apheresis products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
3
0

Year Published

1999
1999
2009
2009

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 24 publications
1
3
0
Order By: Relevance
“…[1][2][3][4][5][6][7][8][9] However, a recent study published in this journal, proved the feasibility and efficacy of TBI-VP 16-CY in paediatric patients with different types of acute leukaemias at various stages. 10 Our single-centre experience confirms the safety and efficacy of this conditioning regimen in children with ALL in 2nd CR, demonstrated by the transplantedrelated mortality (TRM) and disease-free survival (DFS) estimations.…”
Section: Tbi Etoposide and Cyclophosphamide As A Promising Conditionsupporting
confidence: 74%
See 1 more Smart Citation
“…[1][2][3][4][5][6][7][8][9] However, a recent study published in this journal, proved the feasibility and efficacy of TBI-VP 16-CY in paediatric patients with different types of acute leukaemias at various stages. 10 Our single-centre experience confirms the safety and efficacy of this conditioning regimen in children with ALL in 2nd CR, demonstrated by the transplantedrelated mortality (TRM) and disease-free survival (DFS) estimations.…”
Section: Tbi Etoposide and Cyclophosphamide As A Promising Conditionsupporting
confidence: 74%
“…8 Storage of bone marrow on ice, maintaining temperature around 15°C, 9 and in vitro decontamination using pretested antibiotics, should be alternatives to decrease or even eliminate bacterial contamination. 10 Although this is the first report of septic shock due to unrelated bone marrow graft contamination, the clinician must be alert, especially if a long time from collection to infusion is encountered. Moreover, in the event of early signs of bacteremia or shock, antimicrobial therapy must be instituted aggressively to prevent serious consequences.…”
mentioning
confidence: 95%
“…Personnel of donation, collection, or transplantation centers, cell-processing laboratories, and courier services should follow current standards for detecting and preventing extrinsic bacterial and fungal contamination of collected stem cell units at the collection site, during processing and transportation, and at the transplant center [126][127][128][129][130][131][132][133][134][135][136][137][138][139][140][141]. Current, comprehensive discussions of these issues are detailed in the Food and Drug Administration (FDA) ''Good Tissue Practice'' regulations [142], in the European Commission regulations [81], and in international standards established by the professional organizations [76,77,143].…”
Section: Safe Handling Processing and Storage Of Donated Unitsmentioning
confidence: 99%
“…Manipulation during processing, either before or after cryopreservation, may potentially result in bacterial contamination. Bacterial contamination of transplant product has been previously described, and it affects !1%-45% of transplant products [2][3][4][5][6][7]. Depending on the contaminating or-ganism, reinfusion of contaminated product can have serious medical consequences.…”
mentioning
confidence: 99%